93 related articles for article (PubMed ID: 38396702)
1. ADAMTS proteins in human disorders.
Mead TJ; Apte SS
Matrix Biol; 2018 Oct; 71-72():225-239. PubMed ID: 29885460
[TBL] [Abstract][Full Text] [Related]
2. The extracellular matrix in cancer progression: Role of hyalectan proteoglycans and ADAMTS enzymes.
Binder MJ; McCoombe S; Williams ED; McCulloch DR; Ward AC
Cancer Lett; 2017 Jan; 385():55-64. PubMed ID: 27838414
[TBL] [Abstract][Full Text] [Related]
3. Lung Inflammatory Phenotype in Mice Deficient in Fibulin-2 and ADAMTS-12.
Mohamedi Y; Fontanil T; Vega JA; Cobo T; Cal S; Obaya ÁJ
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396702
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the ADAMTS-12 metalloprotease and fibulin-2 induces tumor-suppressive effects in breast cancer cells.
Fontanil T; Rúa S; Llamazares M; Moncada-Pazos A; Quirós PM; García-Suárez O; Vega JA; Sasaki T; Mohamedi Y; Esteban MM; Obaya AJ; Cal S
Oncotarget; 2014 Mar; 5(5):1253-64. PubMed ID: 24457941
[TBL] [Abstract][Full Text] [Related]
5. Neurocan is a New Substrate for the ADAMTS12 Metalloprotease: Potential Implications in Neuropathies.
Fontanil T; Mohamedi Y; Moncada-Pazos A; Cobo T; Vega JA; Cobo JL; García-Suárez O; Cobo J; Obaya ÁJ; Cal S
Cell Physiol Biochem; 2019; 52(5):1003-1016. PubMed ID: 30977985
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells.
Fontanil T; Álvarez-Teijeiro S; Villaronga MÁ; Mohamedi Y; Solares L; Moncada-Pazos A; Vega JA; García-Suárez O; Pérez-Basterrechea M; García-Pedrero JM; Obaya AJ; Cal S
Oncotarget; 2017 Feb; 8(8):13716-13729. PubMed ID: 28099917
[TBL] [Abstract][Full Text] [Related]
7. Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c.
Liu G; Cooley MA; Nair PM; Donovan C; Hsu AC; Jarnicki AG; Haw TJ; Hansbro NG; Ge Q; Brown AC; Tay H; Foster PS; Wark PA; Horvat JC; Bourke JE; Grainge CL; Argraves WS; Oliver BG; Knight DA; Burgess JK; Hansbro PM
J Pathol; 2017 Dec; 243(4):510-523. PubMed ID: 28862768
[TBL] [Abstract][Full Text] [Related]
8. Role of ADAMTS-12 in Protecting Against Inflammatory Arthritis in Mice By Interacting With and Inactivating Proinflammatory Connective Tissue Growth Factor.
Wei JL; Fu W; Hettinghouse A; He WJ; Lipson KE; Liu CJ
Arthritis Rheumatol; 2018 Nov; 70(11):1745-1756. PubMed ID: 29750395
[TBL] [Abstract][Full Text] [Related]
9. Role of ADAM and ADAMTS proteases in pathological tissue remodeling.
Wang Z; Li W; Chen S; Tang XX
Cell Death Discov; 2023 Dec; 9(1):447. PubMed ID: 38071234
[TBL] [Abstract][Full Text] [Related]
10. Challenges and Opportunities Modeling the Dynamic Tumor Matrisome.
Peyton SR; Platt MO; Cukierman E
BME Front; 2023; 4():0006. PubMed ID: 37849664
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of immunity by cigarette smoking promotes inflammation and cancer: A review.
Liu Y; Lu L; Yang H; Wu X; Luo X; Shen J; Xiao Z; Zhao Y; Du F; Chen Y; Deng S; Cho CH; Li Q; Li X; Li W; Wang F; Sun Y; Gu L; Chen M; Li M
Environ Pollut; 2023 Dec; 339():122730. PubMed ID: 37838314
[TBL] [Abstract][Full Text] [Related]
12. The cancer-immune dialogue in the context of stress.
Ma Y; Kroemer G
Nat Rev Immunol; 2024 Apr; 24(4):264-281. PubMed ID: 37833492
[TBL] [Abstract][Full Text] [Related]
13. ADAMTS12 is a stromal modulator in chronic liver disease.
Dekky B; Azar F; Bonnier D; Monseur C; Kalebić C; Arpigny E; Colige A; Legagneux V; Théret N
FASEB J; 2023 Nov; 37(11):e23237. PubMed ID: 37819632
[TBL] [Abstract][Full Text] [Related]
14. Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment.
Attiq A; Afzal S
Front Pharmacol; 2023; 14():1255727. PubMed ID: 37680708
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis.
Yang S; Zhou X; Jia Z; Zhang M; Yuan M; Zhou Y; Wang J; Xia D
Mol Med; 2023 Jul; 29(1):86. PubMed ID: 37400752
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
